X0306 4 2018-02-26 0 0001077183 NEOGENOMICS INC NEO 0001518733 VAN OORT DOUGLAS M 12701 COMMONWEALTH DRIVE SUITE 9 FORT MYERS FL 33913 0 1 0 0 Chairman and CEO Common Stock 187500 I Conundrum Capital Partners Common Stock 1832985 D Stock Option (Right to Buy) 7.15 2017-04-20 2021-04-20 Common Stock 472527 472527 D Stock Option (Right to Buy) 7.52 2018-04-28 2022-04-28 Common Stock 500000 500000 D Restricted Stock 0.00 2018-05-25 Common Stock 197042 197042 D Stock Option (Right to Buy) 8.03 2018-02-26 4 A 0 636000 8.03 A 2019-02-26 2023-02-26 Common Stock 636000 636000 D Conundrum Capital Partners, LLC is a limited liability partnership 50% owned by Mr. VanOort. Mr. VanOort is a managing partner of Conundrum Capital Partners, LLC Includes 125,000 shares of restricted stock that the Board of Directors approved and granted on April 15, 2014. The terms of the award call for the stock to vest on the third anniversary of the grant date as long as Mr. Van Oort is still an employee of the Company. This was disclosed in our Quarterly Report on Form 10-Q as filed with the Securities and Exchange Commission on July 29, 2014. On April 20, 2016, Mr. VanOort was granted 472,527 stock options. These options vest ratably over the first three anniversary dates of the grant date. On April 28, 2017, Mr. VanOort was granted 500,000 stock options. These options vest ratably over the first three anniversary dates of the grant date. Each restricted stock unit represents the contingent right to receive one share of common stock upon vesting of the unit. Restricted stock will vest as follows; 65,680 units will vest on May 25, 2018 and 65,681 units will vest on May 25, 2019 and 2020. These restricted stock units will terminate upon the earliest of death, termination of employment or the last vesting date. On February 26, 2018, Mr. VanOort was granted 636,000 stock options. These options vest ratably over the first three anniversary dates of the grant date. /s/ Douglas M. VanOort 2018-02-28